BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:58 PM
 | 
Aug 29, 2008
 |  BC Extra  |  Top Story

Novartis dropping Aurograb

Novartis (NYSE:NVS; SWX:NOVN) discontinued development of Aurograb after data from a Phase II trial to treat deep-seated Staphylococcus aureus...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >